Compile Data Set for Download or QSAR
Report error Found 59 Enz. Inhib. hit(s) with all data for entry = 50049051
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 0.400nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 0.400nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233522(CHEMBL3932668)
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataKd:  1nMAssay Description:Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.40nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-13 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233524(CHEMBL3981414)
Affinity DataIC50: 1.70nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233523(CHEMBL3931906)
Affinity DataKd:  1.90nMAssay Description:Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 2.60nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233524(CHEMBL3981414)
Affinity DataKi:  4nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233522(CHEMBL3932668)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233526(CHEMBL3983909)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233521(CHEMBL3975922)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233529(CHEMBL4073398)
Affinity DataIC50: 4nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataKi:  4nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233530(CHEMBL4086277)
Affinity DataIC50: 6nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233523(CHEMBL3931906)
Affinity DataKi:  6nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233523(CHEMBL3931906)
Affinity DataIC50: 7nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233522(CHEMBL3932668)
Affinity DataKi:  7nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233523(CHEMBL3931906)
Affinity DataIC50: 7nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233526(CHEMBL3983909)
Affinity DataIC50: 11nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233528(CHEMBL3912535)
Affinity DataIC50: 14nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataKd:  15nMAssay Description:Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233525(CHEMBL4094939)
Affinity DataKi:  19nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233525(CHEMBL4094939)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233525(CHEMBL4094939)
Affinity DataKd:  25nMAssay Description:Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes by TopCount scintillation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataIC50: 25nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-13 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233528(CHEMBL3912535)
Affinity DataKi:  29nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233521(CHEMBL3975922)
Affinity DataKi:  31nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233526(CHEMBL3983909)
Affinity DataKi:  31nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataIC50: 31nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataIC50: 31nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233521(CHEMBL3975922)
Affinity DataIC50: 32nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataKi:  36nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233524(CHEMBL3981414)
Affinity DataIC50: 47nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233530(CHEMBL4086277)
Affinity DataKi:  47nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233529(CHEMBL4073398)
Affinity DataKi:  50nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50442299(CHEMBL2442750)
Affinity DataIC50: 59nMAssay Description:Antagonist activity at DP2 receptor in CD4-positive human TH2 cells assessed as inhibition of DK-PGD2-induced IL-5 production after 6 to 8 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233532(CHEMBL4064804)
Affinity DataKi:  72nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233533(CHEMBL4067518)
Affinity DataIC50: 80nMAssay Description:Antagonist activity at DP2 receptor in human isolated eosinophils assessed as inhibition of DK-PGD2-induced shape change preincubated for 5 mins foll...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233527(CHEMBL3922383)
Affinity DataKi:  86nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233525(CHEMBL4094939)
Affinity DataIC50: 188nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233528(CHEMBL3912535)
Affinity DataIC50: 214nMAssay Description:Antagonist activity at DP2 receptor in human whole assessed as inhibition of DK-PGD2-induced eosinophils shape change preincubated for 5 mins followe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233533(CHEMBL4067518)
Affinity DataKi:  356nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233531(CHEMBL4102679)
Affinity DataKi:  735nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor 2(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233534(CHEMBL4078419)
Affinity DataKi:  1.34E+3nMAssay Description:Displacement of [3H]PGD2 from human DP2 receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP2 subtype(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at EP2 receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin F2-alpha receptor(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at FP receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin D2 receptor(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at DP1 receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
TargetProstaglandin E2 receptor EP4 subtype(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50233520(Fevipiprant | NVP-QAW039 | QAW039)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at EP4 receptor (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2019
Entry Details Article
PubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: